Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Endoplast ApS
APS
Active
CVR 40866442
Håndværkervej 4
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2019
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 26K
-77% vs 2023
EBITDA margin
10.4%
-97% vs 2023
Equity ratio
-102.2%
Financial strength
Net profit 2024
DKK -19K
-135% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 26K
-77%
EBITDA
DKK 3K
-97%
Net profit
DKK -19K
-135%
Total assets
DKK 361K
-1%
Equity
DKK -369K
-5%
Employees
2
—
Company information
Legal name
Endoplast ApS
CVR number
40866442
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
16. oktober 2019
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af direktionen
Company purpose
Selskabets formål er, produktion og salg af dentalplast til tandlæger
Contact
Address
Håndværkervej 4
Email
info@retroplast.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in Stevns
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
35
-109
-463
111
26
Staff expenses
-0
-0
-0
-17
-23
EBITDA
35
-109
-463
94
3
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
35
-109
-463
94
3
Net financials
-6
-5
-18
-25
-25
Profit before tax
30
-114
-481
69
-23
Tax
8
-25
-105
15
-4
Net profit
21
-89
-376
54
-19
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
194
99
283
365
361
Equity
61
-28
-404
-349
-369
Long-term debt
0
0
0
0
0
Short-term debt
132
127
687
714
729
Total debt
132
127
687
714
729
Financial ratios
5-year trend
EBITDA margin
10.4%
This company
15.8%
Market median
-34% vs market
2020
2024
Equity ratio
-102.2%
This company
38.2%
Market median
-368% vs market
2020
2024
Return on equity
-1906400.0%
This company
18.4%
Market median
-10360970% vs market
2020
2024
Net profit margin
-72.9%
This company
8.1%
Market median
-1000% vs market
2020
2024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
2020
2024
Debt / equity
1.98×
This company
0.62×
Market median
-219% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-10-16 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
TF
Thomas Foldberg
Management
Management
2019
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
TACC Holding ApS
Company
100.0%
100.0%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
TACC Holding ApS
Endoplast ApS
(this company)
Board network connections
Board members of Endoplast ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Thomas Foldberg
Management
0 companies